Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Virus Genes"
DOI: 10.1007/s11262-021-01871-8
Abstract: SARS-CoV-2 infections elicit a humoral immune response capable of neutralising the virus. However, multiple variants have emerged with mutations in the spike protein amongst others, the key target of neutralising antibodies. We evaluated the neutralising…
read more here.
Keywords:
protein mutations;
sensitivity;
spike protein;
muc imb ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "Nature Communications"
DOI: 10.1038/s41467-021-23233-6
Abstract: Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring the course and extent of the COVID-19 epidemic. Here, we report estimated seroprevalence in the French population and the proportion of infected individuals…
read more here.
Keywords:
antibodies france;
prevalence sars;
france results;
cov antibodies ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "NPJ Vaccines"
DOI: 10.1038/s41541-021-00311-w
Abstract: mRNA technologies have recently proven clinical efficacy against coronavirus disease 2019 and are among the most promising technologies to address the current pandemic. Here, we show preclinical data for our clinical candidate CVnCoV, a lipid…
read more here.
Keywords:
candidate cvncov;
virus neutralising;
cvncov;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of leukocyte biology"
DOI: 10.1093/jleuko/qiaf033
Abstract: Enhancement of antibody-dependent cellular cytotoxicity (ADCC) is a promising adjunct approach to achieve HIV control in the absence of antiretroviral therapy but requires the development of potent ADCC-eliciting antibodies which can recognise diverse HIV-infected cell…
read more here.
Keywords:
hiv;
broadly neutralising;
hiv infected;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17227
Abstract: The development of anti‐drug antibodies (ADAs) is a serious outcome of treatment strategies involving biological medicines. Coagulation factor VIII (FVIII) is used to treat haemophilia A patients, but its immunogenicity precludes a third of severe…
read more here.
Keywords:
application recombinant;
fviii;
characterisation application;
fviii neutralising ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14669
Abstract: The development of neutralising (inhibitors) and non‐neutralising antibodies (NNAs) is a complication to factor replacement therapy in haemophilia. The diagnostic methods available lack standardisation, have high inter‐laboratory variation, and false‐negative as well as false‐positive results…
read more here.
Keywords:
anti factor;
methods anti;
factor viii;
neutralising antibodies ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Immunology"
DOI: 10.1111/imm.13661
Abstract: SpikoGen® vaccine is a subunit COVID-19 vaccine expressed in insect cells comprising recombinant spike protein extracellular domain formulated with Advax-CpG55.2™ adjuvant. A Phase 2 trial was conducted in 400 adult participants randomised 3:1 to receive…
read more here.
Keywords:
vaccine;
spikogen;
cross neutralising;
neutralising antibodies ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Feline Medicine and Surgery"
DOI: 10.1177/1098612x19845702
Abstract: Objectives Vaccination against feline herpesvirus-1 (FHV-1) is recommended for all cats. However, it is unknown how adult healthy cats with different pre-vaccination antibodies respond to FHV-1 vaccination in the field. The aim of the study…
read more here.
Keywords:
neutralising antibodies;
feline herpesvirus;
response;
adult ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "F1000Research"
DOI: 10.12688/f1000research.149578.2
Abstract: Background Over the past few decades, World Health Organization (WHO) has made massive efforts to promote the development of a vaccine against Lassa virus (LASV), one of the top ten priority pathogens for research and…
read more here.
Keywords:
vaccine development;
development comparison;
neutralising antibodies;
lassa virus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0231967
Abstract: Background Rabies is a vaccine-preventable neglected tropical viral zoonosis. It occurs worldwide, creating a very heavy burden in many developing countries, including Nepal. Dogs are the principle vector for the transmission of this disease in…
read more here.
Keywords:
dogs kathmandu;
virus neutralising;
factors rabies;
associated factors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Antibodies"
DOI: 10.3390/antib14010004
Abstract: Recent avian influenza outbreaks have heightened global concern over viral threats with the potential to significantly impact human health. Influenza is particularly alarming due to its history of causing pandemics and zoonotic reservoirs. In response,…
read more here.
Keywords:
broadly neutralising;
influenza;
redefining immunity;
neutralising antibodies ... See more keywords